InvestorsHub Logo
Followers 3
Posts 481
Boards Moderated 0
Alias Born 11/18/2008

Re: investorgold2002 post# 4916

Wednesday, 08/10/2011 12:07:26 AM

Wednesday, August 10, 2011 12:07:26 AM

Post# of 20689
Why do you assume that?

So I am assuming anti-trust authority would question them as it may likely curtail entry of competition in case of Copaxone.

That's a different topic, isn't it?

Besides contractual agreement with NVS may also preclude such an acquistion before MNTA completes their share of the agreement(which is development and regulatory work for generic copaxone)..